mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |